Search research articles
Contact Us
Filters
Showing results (61-70 of 182) with videos related to
Page
of 19
Sort By:
Human Mutation
|
November 19, 2011
Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications
Tayebeh Soheili, Evelyne Gicquel, Jérôme Poupiot, et al.
Human Gene Therapy
|
February 23, 2013
Prolonged gene expression in muscle is achieved without active immune tolerance using microrRNA 142.3p-regulated rAAV gene transfer
Florence Boisgerault, David-Alexandre Gross, Maxime Ferrand, et al.
Family Practice
|
September 14, 2010
Psychosocial risk factors for chronic low back pain in primary care--a systematic review
Aline Ramond, Céline Bouton, Isabelle Richard, et al.
Research in Developmental Disabilities
|
April 16, 2013
Effect of observation of simple hand movement on brain activations in patients with unilateral cerebral palsy: an fMRI study
Mickael Dinomais, Gregoire Lignon, Eva Chinier, et al.
Molecular Therapy. Methods & Clinical Development
|
June 2, 2015
A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequence
Marina Pryadkina, William Lostal, Nathalie Bourg, et al.
BMC Musculoskeletal Disorders
|
April 18, 2014
Effectiveness of three treatment strategies on occupational limitations and quality of life for patients with non-specific chronic low back pain: Is a multidisciplinary approach the key feature to success: study protocol for a randomized controlled trial
Audrey Petit, Ghislaine Roche-Leboucher, Luc Bontoux, et al.
Human Mutation
|
June 20, 2020
A single c.1715G>C calpain 3 gene variant causes dominant calpainopathy with loss of calpain 3 expression and activity
John Vissing, Julia R Dahlqvist, Carinne Roudaut, et al.
The FEBS Journal
|
January 16, 2009
Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling
Lydie Laure, Laurence Suel, Carinne Roudaut, et al.
Thrombosis Research
|
January 8, 2008
S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood
Alain Rupin, Roger Gaertner, Philippe Mennecier, et al.
Neuromuscular Disorders : NMD
|
March 20, 2021
Late-onset camptocormia caused by a heterozygous in-frame CAPN3 deletion
Marco Spinazzi, Jerome Poupiot, Julien Cassereau, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 182) with videos related to
Sort By:
Page
of 19
Human Mutation
|
November 19, 2011
Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications
Tayebeh Soheili, Evelyne Gicquel, Jérôme Poupiot, et al.
Human Gene Therapy
|
February 23, 2013
Prolonged gene expression in muscle is achieved without active immune tolerance using microrRNA 142.3p-regulated rAAV gene transfer
Florence Boisgerault, David-Alexandre Gross, Maxime Ferrand, et al.
Family Practice
|
September 14, 2010
Psychosocial risk factors for chronic low back pain in primary care--a systematic review
Aline Ramond, Céline Bouton, Isabelle Richard, et al.
Research in Developmental Disabilities
|
April 16, 2013
Effect of observation of simple hand movement on brain activations in patients with unilateral cerebral palsy: an fMRI study
Mickael Dinomais, Gregoire Lignon, Eva Chinier, et al.
Molecular Therapy. Methods & Clinical Development
|
June 2, 2015
A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequence
Marina Pryadkina, William Lostal, Nathalie Bourg, et al.
BMC Musculoskeletal Disorders
|
April 18, 2014
Effectiveness of three treatment strategies on occupational limitations and quality of life for patients with non-specific chronic low back pain: Is a multidisciplinary approach the key feature to success: study protocol for a randomized controlled trial
Audrey Petit, Ghislaine Roche-Leboucher, Luc Bontoux, et al.
Human Mutation
|
June 20, 2020
A single c.1715G>C calpain 3 gene variant causes dominant calpainopathy with loss of calpain 3 expression and activity
John Vissing, Julia R Dahlqvist, Carinne Roudaut, et al.
The FEBS Journal
|
January 16, 2009
Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling
Lydie Laure, Laurence Suel, Carinne Roudaut, et al.
Thrombosis Research
|
January 8, 2008
S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood
Alain Rupin, Roger Gaertner, Philippe Mennecier, et al.
Neuromuscular Disorders : NMD
|
March 20, 2021
Late-onset camptocormia caused by a heterozygous in-frame CAPN3 deletion
Marco Spinazzi, Jerome Poupiot, Julien Cassereau, et al.
Page
of 19